http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6251616-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e34dded9afa83560b12cdec0ef588741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_692dc75829481c48c017b52f352e2bad
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 1985-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff79ec86a7b4ddd1543cc2dfdd2afeac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9349c05054c85ff1053b356a3c97ebe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d500f693e4cdb4e1b7cfbc3a910fa758
publicationDate 1987-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6251616-A
titleOfInvention Glucide transfusion agent
abstract PURPOSE:A glucide transfusion agent, obtained by incorporating palatinose with a specific saccharide or sugaralcohol and suitable for treating hypoglycemia, etc. CONSTITUTION:A glucide transfusion agent obtained by incorporating palatinose with at least one saccharide or sugaralcohol selected from monosaccharides, e.g. glucose or fructose, disaccharides, e.g. maltose, and monosugaralcohol, e.g. sorbitol or xylitol at 7:3-9:1 weight ratio of the saccharide to the sugaralcohol and dissolving the resultant mixture in distilled water for injection to a given concentration, filtering the formed solution through a membranefilter to remove undissolved materials, filling the filtrate in a specified container and sterilizing the filled solution while heating. EFFECT:The osmotic pressure of the palatinose is 1/2 of that of the monosaccharide and the palatinose can be used in a concentration of twice that of the monosaccharide. The palatinose is hydrolyzed into glucose and fructose in the tissue, absorbed and utilized when parenterally administered and both can be simultaneously supplied.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004045312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101018610-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9017744-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9017745-B2
priorityDate 1985-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10125936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226470676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226470677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714

Total number of triples: 42.